Project Wellness: Increasing HIV Testing Among West African Immigrants
|ClinicalTrials.gov Identifier: NCT01270061|
Recruitment Status : Withdrawn (We did not receive proper funding to complete this study)
First Posted : January 5, 2011
Last Update Posted : May 8, 2015
|Condition or disease||Intervention/treatment|
|Diabetes Hypertension HIV||Behavioral: HIV testing Behavioral: General Health Screen|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||0 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Care Provider)|
|Official Title:||Project Wellness: Increasing HIV Testing Among West African Immigrants|
|Study Start Date :||April 2012|
|Estimated Primary Completion Date :||March 2015|
|Estimated Study Completion Date :||June 2015|
Active Comparator: HIV testing
Group 1 (Control) is the current standard of care in HIV testing. A trained counselor provides required information to obtain informed consent for HIV testing and provides rapid HIV testing on site.
Behavioral: HIV testing
HIV education and counseling from a trained Research Assistant and offering of a free rapid, oral HIV test.
Experimental: General Health Screening
In Group 2 (Intervention), a theory-based video is used to obtain informed consent for a free general health screening that includes a blood pressure check, blood glucose measurement, and an HIV test.
Behavioral: General Health Screen
A video will provide health education on diabetes, hypertension, and HIV. The video will then offer free blood pressure check, blood glucose measuring, and a free, rapid oral HIV test.
- HIV testing rate [ Time Frame: up to 1 hour ]rate of participation in voluntary rapid oral HIV test in each group
- Health Knowledge [ Time Frame: up to 1 hour ]Change in knowledge of diabetes, hypertension, and HIV.
- Risk perception [ Time Frame: up to 1 hour ]Change in participants' score on a validated health risk perception measure
- Linkage to care [ Time Frame: up to one year ]Proportion of positively-screened participants that attend follow-up specialized medical care.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01270061
|United States, New York|
|Bronx, New York, United States, 10467|
|Principal Investigator:||Yvette Calderon, MD, MS||North Bronx Healthcare Network|